GenScript, the leading biotech company focused on early drug
discovery and development services, is excited to announce its
upcoming virtual event, the "GenScript 4th Annual Gene and Cell
Engineering Summit," on July 24,
2024.
PISCATAWAY, N.J., July 15,
2024 /PRNewswire-PRWeb/ -- GenScript the leading
biotech company focused on early drug discovery and development
services, is excited to announce its upcoming virtual event, the
"GenScript 4th Annual Gene and Cell Engineering Summit," on
July 24, 2024.
Join GenScript for this one-day event
featuring keynote presentations from invited speakers specializing
in Cell and Gene Therapy research.
This event will feature leading experts from academia, pharma,
and biotech, showcasing the transformative power of synthetic
biology in developing life-changing therapies. Synthetic biology is
revolutionizing life science research, advancing gene and cell
therapies, and facilitating the efficient development of
biotherapeutics for various human diseases.
Committed to "Making People and Nature Healthier through
Biotechnology," GenScript partners with scientists globally to
facilitate research and expedite discoveries through its advanced
platforms. Join us for this one-day event featuring keynote
presentations from invited speakers specializing in Cell and Gene
Therapy research.
The exciting lineup includes:
- Opening remarks and an introduction to the event program by Ms.
Sherry Shao, Rotating CEO of
GenScript Biotech.
- Dr. Jason Zhang, Co-Founder and
CEO of Zipcode Bio, presents first on "Exploring the Development
& Optimization of mRNA Delivery Systems to Advance mRNA-based
Medicines." This keynote will provide an exploration of these
approaches, highlighting the progress made and the future
directions for this promising field.
- Dr. Samuel H. Sternberg,
Associate Professor in the Department of Biochemistry and Molecular
Biophysics at Columbia University,
highlights an elegant expansion of genome coding potential through
RNA-templated gene creation, and challenges conventional paradigms
of genetic information encoded along the one-dimensional axis of
genomic DNA in his presentation "De novo gene synthesis by an
antiviral reverse transcriptase."
- Dr. Branden Moriarty, Associate
Professor at the University of
Minnesota Medical School, will discuss the limitations of
immunotherapy using chimeric antigen receptor (CAR) expressing NK
cells engineered via viral vectors and the methods to overcome
these shortcomings in his presentation "Cytokine Armored CAR-NK
Cell Therapy for Advanced Ovarian Cancer."
- Dr. Sandeep Kumar, Senior
Director of Platform Development at Tome Biosciences, will present
on "Programmable Genomic integration (PGI): a technology that
enables the integration of large DNA sequences at specific genomic
locations." His talk will provide an overview of PGI and highlight
the progress Tome has made in developing this technology into
medicine for patients in need.
- Dr. Fred Parietti, Co-founder
and CEO of Multiply Labs, will present on "The Power of Automation:
How Robotics Can Dramatically Reduce Cell Therapy Manufacturing
Costs and Scale Patient Access." This talk will explore the
cutting-edge developments made this year in finally bringing
automation to cell therapy manufacturing.
- Dr. Michelle Hung, Principal
Scientist at GeneFab, will present several case studies of how
GeneFab's team has delivered on complex projects to enable their
clients to develop next-generation pipeline products in her talk
"Synthetic biology approaches to improve cell therapy
function."
- Dr. Sergej Kudruk, Postdoctoral Fellow at Northwestern University and the International
Institute for Nanotechnology, will present on "Advancing Gene
Editing Technologies with Spherical Nucleic Acids (SNA)." Here he
will discuss the important work that underscores the precise
control over molecular interactions at the nanoscale and the
potential of SNA-based nanotechnologies for gene editing
applications.
- Dr. Dong Geng, the VP, Head of
Early-stage Drug Development at Legend Biotech will discuss how
cell therapies targeting autoreactive immune cells may offer a
potentially curative approach in certain autoimmune diseases in her
presentation "Autoimmune Diseases, the Arising Opportunities for
Cell Therapies."
- Finally, Dr. Raymond Miller,
Director of Brand Management, GenScript USA Inc, will deliver closing remarks for the
day.
The event is tailored for life science researchers, laboratory
professionals, pathologists, and anyone involved in gene and cell
engineering. In addition to the presentations, attendees can
participate in interactive sessions, visit the exhibit hall, chat
with attendees in the networking lounge, and engage in real-time
Q&A sessions with expert speakers.
For further information about the event and to register for
free, click here.
About GenScript
As a leading contract research organization (CRO), GenScript,
headquartered in Piscataway, New
Jersey, provides comprehensive solutions for researchers
worldwide, offering services in gene synthesis, peptide synthesis,
protein engineering, CRISPR tools, mRNA synthesis, custom antibody
generation, and more. Since 2001, GenScript has expanded its
capabilities through strategic growth and partnerships,
establishing itself as a leader in biological research
services.
GenScript is dedicated to making research easy, offering
complete solutions for investigators developing gene and cell
therapies through viral, non-viral CRISPR, and mRNA strategies. For
more information, please visit http://www.genscript.com.
About Labroots
Labroots is the leading scientific social networking website, and
primary source for scientific trending news and premier educational
virtual events and webinars and more. Contributing to the
advancement of science through content sharing capabilities,
Labroots is a powerful advocate in amplifying global networks and
communities. Founded in 2008, Labroots emphasizes digital
innovation in scientific collaboration and learning. Offering more
than articles and webcasts that go beyond the mundane and explore
the latest discoveries in the world of science, Labroots users can
stay atop their field by gaining continuing education credits from
a wide range of topics through their participation in the webinars
and virtual events.
Media Contact
Akshay Masand, Labroots,
1-714-463-4673, akshay.masand@labroots.com, www.labroots.com
View original content to download
multimedia:https://www.prweb.com/releases/genscript-announces-4th-annual-gene--cell-engineering-virtual-summit-302197353.html
SOURCE Labroots